Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids

Am J Respir Crit Care Med. 2009 Mar 15;179(6):474-83. doi: 10.1164/rccm.200807-1064OC. Epub 2009 Jan 8.

Abstract

Rationale: Acute lung injury (ALI) remains an important cause of mortality in intensive care units. Inflammation is controlled by cytokines and eicosanoids derived from the n-6 fatty acid (FA) arachidonic acid (AA). The n-3 FA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and mediators derived from EPA and DHA possess reduced inflammatory potency.

Objectives: To determine whether the ability of fat-1 mice to endogenously convert n-6 to n-3 FA, and thus generate an increased ratio of n-3 to n-6 FA, impacts experimental ALI.

Methods: We investigated ALI induced by intratracheal instillation of endotoxin in fat-1 and wild-type (WT) mice, assessing leukocyte numbers, protein concentration, and prostaglandin and cytokine levels in bronchoalveolar lavage fluid, as well as free FA in plasma, and lung ventilator compliance. Body temperature and motor activity of mice--markers of sickness behavior--were also recorded.

Measurements and main results: In ALI, fat-1 mice exhibited significantly reduced leukocyte invasion, protein leakage, and macrophage inflammatory protein-2 and thromboxane B(2) levels in lavage fluid compared with WT mice. Free AA levels were increased in the plasma of WT mice in response to endotoxin, whereas EPA and DHA were increased in the fat-1 group. Ventilator compliance was significantly improved in fat-1 mice. Body temperature and motor activity were decreased in ALI. fat-1 Mice recovered body temperature and motor activity faster.

Conclusions: fat-1 Mice exhibited reduced features of ALI and sickness behavior. Increasing the availability of n-3 FA may thus be beneficial in critically ill patients with ALI.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / metabolism*
  • Acute Lung Injury / prevention & control*
  • Animals
  • Arachidonic Acid / metabolism
  • Behavior, Animal
  • Body Temperature
  • Bronchoalveolar Lavage Fluid / chemistry
  • Caenorhabditis elegans Proteins / genetics
  • Caenorhabditis elegans Proteins / metabolism
  • Chemokine CXCL2 / analysis
  • Disease Models, Animal
  • Docosahexaenoic Acids / metabolism
  • Eicosapentaenoic Acid / metabolism*
  • Fat Emulsions, Intravenous / pharmacology
  • Fatty Acid Desaturases / genetics
  • Fatty Acid Desaturases / metabolism
  • Fish Oils / pharmacology
  • Leukocyte Count
  • Leukocytes / pathology
  • Lung / metabolism
  • Lung / pathology
  • Mice
  • Mice, Transgenic
  • Motor Activity
  • NF-kappa B / metabolism
  • Respiration, Artificial
  • Thromboxane B2 / analysis
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Caenorhabditis elegans Proteins
  • Chemokine CXCL2
  • Cxcl2 protein, rat
  • Fat Emulsions, Intravenous
  • Fish Oils
  • NF-kappa B
  • Tumor Necrosis Factor-alpha
  • fat-1 protein, C elegans
  • Docosahexaenoic Acids
  • Arachidonic Acid
  • Thromboxane B2
  • Eicosapentaenoic Acid
  • Fatty Acid Desaturases